Xiaolin Lü

3.1k citations
124 papers · 2.6k · h-index 27

Impact in

    • Cancer-related molecular mechanisms research
    • MicroRNA in disease regulation
    • Circular RNAs in diseases
    • RNA modifications and cancer
    • Epigenetics and DNA Methylation
    • Extracellular vesicles in disease

Papers in

    • Epigenetics and DNA Methylation 15
    • RNA modifications and cancer 10
    • Circular RNAs in diseases 9
    • Hedgehog Signaling Pathway Studies 6
    • Cancer-related molecular mechanisms research 14
    • MicroRNA in disease regulation 12

Xiaolin Lü

121 papers receiving 2.6k citations

Peers

Xiaolin Lü
Comparison fields: 5 of 133
  • Cancer Research 922
  • Molecular Biology 1.4k
  • Rheumatology 170
  • Renewable Energy, Sustainability and the Environment 161
  • Oncology 231
Replace Hongqian Guo with:
Hongqian Guo China
Yubin Ge United States
Ulrich Bergmann Finland
Rona Singer Weinberg United States
Chunyang Jiang China
Hua Zhou China
Thomas J. Lawton United States
Javier Silva Spain
Masaaki Tachibana Japan
Masahiko Hosaka Japan
Xiaolin Lü relative to Hongqian Guo China Hongqian Guo's profile →
Citations per field
00.5×4.2×
Hongqian Guo · 1×
Citations per year

Countries citing papers authored by Xiaolin Lü

Since Specialization
Citations

This map shows the geographic impact of Xiaolin Lü's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaolin Lü with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaolin Lü more than expected).

Fields of papers citing papers by Xiaolin Lü

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaolin Lü. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaolin Lü. The network helps show where Xiaolin Lü may publish in the future.

Co-authors

The 25 scholars most cited alongside Xiaolin Lü, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xiaolin Lü Line = papers co-authored together Xiaolin Lü links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 124 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2015247
2 2013158
3 2014117
4 201679
5 201475
6 201575
7 201072
8 201870
9 201770
10 201569
11 201668
12 201656
13 201455
14 201451
15 202350
16 201647
17 201545
18 201444
19 201440
20 201535

About Xiaolin Lü

Xiaolin Lü is a scholar working on Molecular Biology, Cancer Research, Rheumatology, Pulmonary and Respiratory Medicine and Pediatrics, Perinatology and Child Health, having authored 124 papers that have together received 2.6k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (15 papers), Cancer-related molecular mechanisms research (14 papers), Folate and B Vitamins Research (14 papers), MicroRNA in disease regulation (12 papers), RNA modifications and cancer (10 papers), Circular RNAs in diseases (9 papers), Hedgehog Signaling Pathway Studies (6 papers) and Acupuncture Treatment Research Studies (4 papers). The work is most often cited by research in Cancer Research (922 citations), Molecular Biology (1.4k citations), Rheumatology (170 citations), Renewable Energy, Sustainability and the Environment (161 citations) and Oncology (231 citations). Xiaolin Lü has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Qizhan Liu, Yi Liu, Fei Luo, Le Shi, Lu Lu, Xinlu Liu, Wenchao Xu, Bairu Wang, Yue Xu and Fei Luo. Their work appears in journals such as Toxicology Letters, Birth Defects Research Part A Clinical and Molecular Teratology, Analytical Methods, Oncotarget and Toxicology and Applied Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact